Rothschild Investment LLC Bridge Bio Pharma, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 250 shares of BBIO stock, worth $8,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 165
51.52%
Holding current value
$8,210
Previous $4.53 Million
90.88%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
361Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$724 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$633 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$489 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$409 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$236 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.87B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...